Glenda Pearson provides her contact information and experience as a Clinical Research Associate. She has over 20 years of experience as a registered nurse and clinical research coordinator. Her roles have included clinical site management, establishing relationships with sponsors and vendors, ensuring compliance with regulations, and educating patients. She believes in the ability of research to cure disease and has extensive knowledge of clinical trials and good clinical practice guidelines.

1. GLENDA PEARSON, RN, CRA
ADDRESS:​ 108 Campion, Dr. Waveland MS 39576 ​PHONE:​ 228.671.7903 ​EMAIL:​ glendapearson411@gmail.com
CLINICAL RESEARCH ASSOCIATE (CRA)
DECLARE THE PAST, DIAGNOSE THE PRESENT, FORETELL THE FUTURE..HIPPOCRATES
I BELIEVE IN RESEARCH AND ITS' ABILITY TO CURE DISEASE! I HAVE A GREAT PASSION FOR
RESEARCH AND THE
POSITIVE AFFECTS WORKING IN UNITY AS A TEAM HAS ON THE HUMAN SPIRIT! GIVING THOSE
WHO HAVE ENTRUSTED
THEMSELVES TO US, THE CONFIDENCE THAT WE ARE WORKING FOR A POSITIVE STUDY OUTCOME
FOR ALL.
CORE COMPETENCIES
Extensive knowledge of the clinical trial
process
Skilled at rapid conflict resolution
Clinical site management
Ability to work with minimal supervision
Comprehensive knowledge of GCP,
Clinical guidelines,
Clinical Regulatory requirements
Establish and maintain professional
working relationships
Excellent time management skills
Detail oriented
EDUCATION AND CREDENTIALS
1996 Associate’s Degree, Registered Nurse
Pearl River College
2005 CCRC Certified Clinical Research Coordinator
ACRP
2012 Emergency Management Institute
IS­00700.a
U.S. Department of Homeland Security
National Incident Management System Certificate (NIMS)
2013 GCP Good Clinical Practice Curriculum
Brookewood, INC
2008 Sixth Edition
Page 1​ of 8

2. GLENDA PEARSON, RN, CRA
ADDRESS:​ 108 Campion, Dr. Waveland MS 39576 ​PHONE:​ 228.671.7903 ​EMAIL:​ glendapearson411@gmail.com
GCP Reference Guide Review
2013 Medpace Medical Device
Coordinator InForm Training
Version 3, 01Aug2011
2015 CLD­CP­Health Literacy
2015 Nutrition & Energy
Education for patients using Chemotherapy medications
PROFESSIONAL EXPERIENCE
2015­Present Care Manager
Giving Tree MS
● Responsible for providing comprehensive assessment
● Planning implementation and over evaluation of individual clients needs
● Work with agencies and service providers to facilitate case coordination and
information sharing
● Help the client to understand their conditions and treatment options
● Communicate with physicians and develop working relationship
● Help client and families to make informed decisions
● Review treatment goals and resources
● Provide education and literature about diagnosis
● Participate in the development and implementation of client care policies and
protocols
● Promote effective and efficient utilization of clinical resources
2013­2014 CCRC
Heart Clinic of Hammond – Hammond La.
● Worked with Principal Investigator to conduct studies in accordance with (
GCP) Good Clinical Practice, (NIH ) National Institutes of Health
,(HIPAA) Health Insurance Portability and Accountability Act and
● ( FDA,)Food and Drug Administration regulations.
● Developed subject recruitment plans
● Developed site processes to comply with appropriate protocol and
regulatory procedures.
Page 2​ of 8

3. GLENDA PEARSON, RN, CRA
ADDRESS:​ 108 Campion, Dr. Waveland MS 39576 ​PHONE:​ 228.671.7903 ​EMAIL:​ glendapearson411@gmail.com
● Facilitated sponsor site visits, site selection visits, interim monitoring and
study closeouts
● Worked with (FCE) Field Clinical Engineer, Med/Guarding System,
(IMD), Implantable device that collects and analyzes EKG segments to
detect significant changes in ST “Shift” 24 hours a day.
● Education to patients concerning alarms associated with IMD
● Monitored all adverse reactions, data collection, Protocol deviations ,EXD
replacement, maintain study integrity in house monitoring, worked with
PI, to conduct study in accordance with, Declaration of Helsinki and all
applicable regulations.
● Reviewed source documents and subject medical records confirming
records were attributable, legible, contemporaneous, original, and accurate
and complied with 21CFR 58.130 (15) Alcoa governing regulations
● Manually reviewed subject data in EDC.
HIGHLIGHTS:
ESTABLISHED STRONG AND EFFECTIVE WORKING RELATIONSHIPS WITH SPONSOR
AND VENDORS THROUGH OPEN COMMUNICATIONS, BASED ON TRUST, AND COMMITMENT IN A
PROFESSIONAL MANOR.
2006–2010 Clinical Research Coordinator
Northshore Regional Medical Center – Slidell La
● Coordinated with Principal Investigator and Administration to ensure
research was conducted in accordance with FDA guidelines and sponsor
specific protocols.
● Assisted with investigation study selection and project negotiation.
● Attend investigator meetings required or requested by the PI
● Provide support to study coordinators pertaining to issues affecting clinical
trial conduct.
● Maintained SOP.GCP, and ICH guidelines.
● Review and develop a familiarity with the protocol, e.g. study proceedings
and time lines, inclusion, exclusion criteria, confidentiality following all
HIPAA, regulations with regard to patients privacy.
● Assist with submission of accurate and timely closeout documents.
1999­Present ​Community Based Charge Nurse
Hancock Medical Center
Page 3​ of 8

4. GLENDA PEARSON, RN, CRA
ADDRESS:​ 108 Campion, Dr. Waveland MS 39576 ​PHONE:​ 228.671.7903 ​EMAIL:​ glendapearson411@gmail.com
Bay St. Louis, MS
● Performed physical assessments for patients
● Administration of medications as needed.
● Perform glucose checks,
● Triage, administration of emergency care with stabilization until the
patient is transferred to appropriate unit.
● Responsibilities in pre­op and post­op acute settings include but not
limited to: pre­op patient assessment,
● Medical HX, current labs, X­Rays, IV therapy, Vital signs, 02 therapy,
wound care using sterile procedure,pain management .
● Distribution of age appropriate procedure instructions with emphasis for
required follow­up with treating physicians.
● Immunization and yearly flu immunization program as directed through
community­based clinic policy and procedures.
● Maintain and update computer literacy on an on going basis.
● Instruct patients with diabetes on insulin pump, insulin use, diet, infection
control, proper exercise.
● Preformed drug screenings and physicals for new employees at Port
Bienville Clinic.
● Maintained Special Needs Shelter in community setting during Hurricane
Katrina!
● Held community out­reach Health Fair.
1996­1999 RN Charge Nurse
Slidell Memorial Hospital ­ Slidell LA
Charge nurse for Rehabilitation Unit
Assigned all patient care, assessment of Code Cart each shift.
● Coordinated patient admissions and transfers.
● Performed Comprehensive physical assessments
● Distribution of medications
● Preformed all blood transfusions
● Lab draws to Central Lines
● Worked with PT, ST and OT to provide safe environment for all patients
● Maintained close working relationships with treating physicians, all staff,
as well as families to facilitate, and educate all involved to reach goals
implemented for patients recovery.
● Monitor all data for unit, monitored patients charts.
Page 4​ of 8

5. GLENDA PEARSON, RN, CRA
ADDRESS:​ 108 Campion, Dr. Waveland MS 39576 ​PHONE:​ 228.671.7903 ​EMAIL:​ glendapearson411@gmail.com
● Made sure all documents needed were up to date according to all
regulations
● Facilitated all referrals, transfers, and discharge of patients.
HIGHLIGHTS:
✓ As charge nurse I supervised and delegated duties to LPN’s and Nursing
assistants.
PROFESSIONAL DEVELOPMENT
AFFILIATIONS
TECHNICAL SKILLS
Microsoft Office Suite (Word, Excel, and PowerPoint)
Microsoft Publisher
Internet Applications
Various electronic case report form (eCRF) systems, EDC systems and study databases
RESEARCH STUDIES
037–01/ERT156 A prospective, multicenter, double­blind with in­house blinding,
randomized, comparative study to evaluate the efficacy, safety, and tolerability of
ertapenem sodium versus piperacillin­tazobactam in the treatment of complicated
intra­abdominal infections in hospitalized adults.
​051–356 A long­term safety study of levalbuterol and racemic albuterol in subjects twelve
years of age and older with asthma.
156–03–236 Multicenter randomized, double­blind, placebo­controlled study to evaluate
the long term efficacy and safety of oral tolvaptan tablets in subjects hospitalized
with worsening congestive heart failure​.
322 A multicenter, randomized, double­blind, double­dummy, parallel­group efficacy
study comparing 8 weeks of treatment with esomeprazole magnesium (40 mg qd) to
Page 5​ of 8

6. GLENDA PEARSON, RN, CRA
ADDRESS:​ 108 Campion, Dr. Waveland MS 39576 ​PHONE:​ 228.671.7903 ​EMAIL:​ glendapearson411@gmail.com
lansoprazole (30 mg qd) for the healing of erosive esophagitis in patients with
moderate or severe erosive esophagitis.
325 A multicenter, randomized, double­blind, double­dummy, parallel­group comparison
of the remission rates for once daily treatment with esomeprazole 20 mg and
lansoprazole 15 mg for 6 months in patients whose erosive esophagitis has been
healed​.
1502–IMIQ Entitled phase 3b, open­label effectiveness and safety of imiquimod 5%
topical cream in the treatment of actinic keratosis​.
2993–113 A phase 3, randomized, triple­blind, parallel­group, long­term,
placebo­controlled, multicenter study to examine the effect on glucose control (HbA
1c) of AC2993 given two times a day in subjects with type 2 diabetes mellitus treated
with a sulfonylurea alone​.
2993–113E ​An open­label extension study of protocol 2993­113 to examine the long­term
effect on glucose control (HbA1c) and safety and tolerability of AC2993 given two
times a day in subjects with type 2 diabetes mellitus. ​2993–116 A phase 2,
randomized, triple­blind, placebo­controlled, short­term, dose­response study to
examine the effect on glucose control and safety and tolerability of AC2993 given
two times a day in subjects with type 2 diabetes mellitus.
2993–119 An open­label study to examine the long­term effect on glucose control (HbA1c)
and safety and tolerability of AC2993 given two times a day to subject with type 2
diabetes mellitus.
CCIB00212301 a prospective, multinational, multicenter, double­blind, randomized,
active­controlled trial to compare the effects of lotrel (amlodipine/benzapril) to
benzapril and hydrochlorothiazide combined on the reduction of cardiovascular
morbidity and mortality in patients with high risk hypertension​.
D9619C00001 A multicenter, randomized, double­blind, parallel­group,
placebo­controlled efficacy study comparing 4 weeks of treatment with
esomeprazole 20 mg qd for the resolution of upper abdominal pain in patients with
symptomatic gastroesophageal reflux disease (sGERD).
D961AC00001 A multicenter, randomized, double­blind, placebo­controlled efficacy study
comparing 4 weeks of treatment with esomeprazole 20mg qd and 40 mg qd to
Page 6​ of 8

7. GLENDA PEARSON, RN, CRA
ADDRESS:​ 108 Campion, Dr. Waveland MS 39576 ​PHONE:​ 228.671.7903 ​EMAIL:​ glendapearson411@gmail.com
placebo qd in patients with heartburn and sleep disturbances associated with
gastroesophageal reflux disease (GERD).
EFC4736 A randomized, double­blind, placebo­controlled, fixed­dose, multicenter study of
weight­reducing effects and safety of SR141716 in obese patients with type 2
diabetes​.
GLP107294: A 17­week, parallel­group, double­blind, randomized, placebo­controlled,
multicenter, dose­ranging study to evaluate the efficacy, safety, and tolerability of
four doses of GSK716155, with Byetta as an open­label active reference, in subjects
with type 2 diabetes mellitus​.
HOE 901/4033 (GOAL A1c) a diabetic study​.
LOFBIV–PCAP–003 A phase 3 (PRI/LOF­INT­1) a multicenter, randomized, open­label,
comparative study to compare the efficacy and safety of levofloxacin and standard
of care therapy in the treatment of children with community­acquired pneumonia in
the hospitalized or outpatient setting (RWJ­25213­097).
LOFBO–LTSS–001 Phase 3 (PRI/LOF–INT–4) a multicenter, long­term,
active­surveillance study of musculoskeletal disorder that occur after initiating a
course of levofloxacin (RWJ–25213–097) or non­fluoroquinolone therapy for acute
infectious diseases in children who were enrolled in phase 3 clinical trials involving
levofloxacin therapy.
LOFBO–OTMD–002 Phase 3 (PRI/LOF–INT–2) a multicenter, randomized, comparative
study of evaluate the efficacy and safety of levofloxacin in the treatment of children
who have recurrent and/or persistent acute otitis media (RWJ–25213–097)​.
S3B0048 A 12­week, randomized double­blind, placebo­controlled study with PRN bid and
fixed dosing regimens of alosetron in female subjects with severe
diarrhea­predominant irritable bowel syndrome who have failed conventional
therapy​.
SD–004–0758 (Pulmicort Respules) Rates of seroconversion following varicella
vaccination of asthmatic children between the ages of one and eight years treated
with Pulmicort Respules versus non­steroidal conventional asthma therapy.
Page 7​ of 8

8. GLENDA PEARSON, RN, CRA
ADDRESS:​ 108 Campion, Dr. Waveland MS 39576 ​PHONE:​ 228.671.7903 ​EMAIL:​ glendapearson411@gmail.com
References:
Deborah Carter
CRA II PPDI
Mobile: 504­237­3171
Sherry Raziano, LPN, BS, CRA I
15030 Clear Springs Dr.
Biloxi MS
Mobile: 228­234­2169
Martena Jamison, RN BSN
Ridgeland, MS
Mobile:228­342­0985
Kelli Cannon, RN, CRA III
Mobile: 985­774­3122
Page 8​ of 8